Salute e Benessere

Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030…

Key Takeaways from the Chemotherapy Drugs Market Report Key Takeaways from the Chemotherapy Drugs Market Report To read more about the latest highlights related to the chemotherapy drugs market, get a snapshot of the key highlights entailed in the Global Chemotherapy Drugs Market Report Chemotherapy Drugs Overview Chemotherapy drugs are powerful medications used to treat cancer by targeting and destroying rapidly dividing cells, a hallmark of cancerous growth. These drugs can...
PR Newswire
22/08/2024

Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA…

The Company further announced that following a thorough evaluation of BI's manufacturing controls and raw materials, all its products successfully met the stringent quality standards set by the FDA, fulfilling all compliance requirements necessary for the completion of MoCRA registration. The Company further announced that following a thorough evaluation of BI's manufacturing controls and raw materials, all its products successfully met the stringent quality standards set by the FDA…
PR Newswire
22/08/2024

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of…

Company announcement – No. 41 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, August 22, 2024–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 13,000 divided into 13,000 new shares with a nominal value of DKK 1...
Nasdaq GlobeNewswire
22/08/2024

Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron…

The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage and is recommended for individuals 6 months of age and olderThe KP.2 adaptation is based on FDA guidance, which stated that KP.2 is the preferred strain for COVID-19 vaccines for the US 2024-2025 fall and winter season, if feasibleShipping will begin immediately to ensure robust supply and rapid access of this season's vaccine in pharmacies, hospitals, and clinics across the country ...
Nasdaq GlobeNewswire
22/08/2024

Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But…

In its decision, MHRA confirms what the scientific community and multiple other health regulatory agencies have long known — lecanemab is safe, effective and beneficial for people in the early stages of Alzheimer's or living with mild cognitive impairment (MCI). The U.K. joins the U.S., China, South Korea, Israel, Hong Kong and Japan in its approval of Leqembi. In its decision, MHRA confirms what the scientific community and multiple other health regulatory agencies have long known —…
PR Newswire
22/08/2024

KFSHRC Sets New Global Standards with VR Technology at AMEE 2024

RIYADH, Saudi Arabia, Aug.22, 2024(GLOBE NEWSWIRE) -- By continuously adopting new technologies, KFSHRC ensures that its trainees are well-prepared for today's medical challenges and equipped with the skills and knowledge needed to lead the future of medicine. These technologies bridge the gap between theory and practice and prepare healthcare professionals to lead in an increasingly complex and technology-driven healthcare landscape.King Faisal Specialist Hospital & Research...
Nasdaq GlobeNewswire
22/08/2024

Trudell Medical Limited expanding into respiratory diagnostics with agreement to…

The purchase is subject to court approval and is expected to close in 8-12 weeks. The acquisition will expand Trudell Medical's already strong market position in aerosol drug delivery and lung health devices to include respiratory diagnostics. The purchase is subject to court approval and is expected to close in 8-12 weeks. The acquisition will expand Trudell Medical's already strong market position in aerosol drug delivery and lung health devices to include respiratory diagnostics. Trudell...
PR Newswire
22/08/2024

Speaking Valves Market worth $128 million by 2029 driven by Emerging Tech…

Browse in-depth TOC on "Speaking Valves Market " Browse in-depth TOC on "Speaking Valves Market " 140 - Tables50 - Figures173 - Pages Coloplast A/S: Market Leader in Speaking Valves Coloplast A/S ( Denmark ) emerged as the leading player in the global speaking valves market in 2023. The company maintains a strong presence acrossEurope,North America, andAsia, driven by its significant investments in research and development. Coloplast's...
PR Newswire
22/08/2024

Optellum showcases AI-powered precision lung interventions at AABIP 2024

Minimally invasive endobronchial biopsies, using robotic bronchoscopes under advanced imaging guidance, are state-of-the-art in lung tissue diagnosis. Combining such devices with the power of Optellum's Virtual Nodule Clinic AI platform will transform the precision, speed, and efficiency of the lung cancer care pathway. Nodule programs powered by Optellum's AI platform have been shown to efficiently increase the volume of patients [1] and enable clinicians to make more informed decisions about…
PR Newswire
22/08/2024

U.K. Hospitality Industry Faces Significant Challenges Amid Labour Shortages and…

Employee morale is also suffering, with almost half of managers acknowledging the negative impact of staff shortages. Primary consequences of these shortages are cited as increased workloads (73%) and higher employee turnover (60%). Customer experience is reported to be deteriorating as a result, with half of respondents noting longer waiting times and a concerning 41% observing a decline in the quality of service. Employee morale is also suffering, with almost half of managers acknowledging...
PR Newswire
22/08/2024

Oblique Therapeutics has entered a research collaboration agreement with Eli…

The parties already have an existing agreement in place (signed in November 2023) and this agreement expands the collaboration between the companies to a second high-value target. The parties already have an existing agreement in place (signed inNovember 2023 ) and this agreement expands the collaboration between the companies to a second high-value target. " We are delighted to expand the collaboration between our companies and together create new science to address the unmet medical…
PR Newswire
22/08/2024

BRITISH BEAUTY INDUSTRY'S RESILIENCE REINFORCED BY MARKET GROWTH AND FORECASTED…

- The beauty industry's annual growth rate is forecasted to be higher than the national average in 2024, expected to peak at 3% YOY. - The beauty industry's annual growth rate is forecasted to be higher than the national average in 2024, expected to peak at 3% YOY. LONDON , Aug. 22, 2024 /PRNewswire/ -- The British beauty industry grew by an impressive 11 per cent last year – with signs it is shaking off the triple hangovers of Brexit, Covid and the cost of living crisis, new...
PR Newswire
22/08/2024

Alkermes Announces Initiation of Vibrance-2 Phase 2 Study Evaluating ALKS 2680…

Vibrance-2 is a phase 2, randomized, double-blind, dose-range-finding, placebo-controlled study evaluating the safety and efficacy of ALKS 2680 in adults with NT2. Participants will be randomized to receive one of three doses of ALKS 2680 (10 mg, 14 mg or 18 mg) or placebo to be taken once-daily for eight weeks. The primary endpoint will assess whether participants taking ALKS 2680 experience a greater decrease in sleepiness compared to participants taking placebo alone, as measured by the…
PR Newswire
22/08/2024

Zymeworks Announces Participation in Upcoming Investor Conferences

Wells Fargo Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on September 4 at 8:45 am Eastern Time (ET) in Boston, MA.Morgan Stanley 22 ndAnnual Global Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on September 5 at 7:00 am ET in New York, NY.H.C. Wainwright 26 thAnnual Global Investment Conference: Zymeworks' management will participate in one-on-one meetings and a...
Nasdaq GlobeNewswire
22/08/2024

Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for…

Edward Yoon, MD, Chief of Interventional Radiology, Hospital for Special Surgery located in New York City, commented "I am excited for the opportunity to share my personal experience with NIMBUS with my colleagues in the United Kingdom. I have been using NIMBUS since my Fellowship and delighted with our patient outcomes with this technology. I am appreciative of Stratus Medical who supports professional education in the UK, US, and other countries across the world." Edward Yoon, MD…
PR Newswire
22/08/2024

Leqembi (lecanemab) authorized for early Alzheimer's disease in Great Britain

Lecanemab selectively binds to Aβ aggregate species, with preferential activity for toxic Aβ protofibrils[3] (as well as fibrils, which are a major component of Aβ plaques). Lecanemab binds to these aggregate Aβ species to neutralize and clear them from the brain. [4],[5],[6] Lecanemab selectively binds to Aβ aggregate species, with preferential activity for toxic Aβ protofibrils [3] (as well as fibrils, which are a major component of Aβ plaques). Lecanemab binds to these aggregate Aβ species...
PR Newswire
22/08/2024

Energy Gum Market to Reach $263.4 Million, Globally, by 2035 at 7.9% CAGR…

Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A04227 Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A04227 Prime determinants of growth Growth in health consciousness results in consumers participating in sports, gymnastics, yoga, and other workout activities. Energy gum helps maximize performance during workouts, to overcome sleep deprivation and fatigue during late-night work. The surge in the number of middle-aged and young...
PR Newswire
22/08/2024

Frost & Sullivan published AI Medical Imaging Bluepaper and FOSUN AITROX is…

AI can play a crucial role in medical diagnostics. AI models can improve the sensitivity, specificity, and other key parameters of disease diagnoses, particularly in areas such as image enhancement, lesion identification, 3D reconstruction, and automated reporting. As algorithm models continue to improve, they can identify abnormalities that are indiscernible to the naked eye. In certain specific disease diagnoses, AI has achieved accuracy comparable to that of highly experienced medical…
PR Newswire
22/08/2024

Orion Corporation: Managers' transactions – Satu Ahomäki

ORION CORPORATIONMANAGERS' TRANSACTIONS22 AUGUST 2024 at 10.30 EEST Orion Corporation: Managers' transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification...
Nasdaq GlobeNewswire
22/08/2024

Regarding rumors of an imminent approval of lecanemab in Great Britain…

For further information, please contact: Oskar Bosson, VP Communications and IRE-mail: oskar.bosson@bioarctic.sePhone: +46 70 410 71 80 For further information, please contact: Oskar Bosson, VP Communications and IR E-mail: oskar.bosson@bioarctic.sePhone: +46 70 410 71 80 About BioArctic ABBioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented...
PR Newswire
22/08/2024

Invitation and registration for Essity's Capital Markets Day on December 3, 2024

Use the link below to register your participation no later than October 1. The number of seats is limited, and priority will therefore be given to institutional investors, financial analysts and financial media. Use the link below to register your participation no later thanOctober 1. The number of seats is limited, and priority will therefore be given to institutional investors, financial analysts and financial media. Register for Essity's Capital Markets Dayhere The Capital...
PR Newswire
22/08/2024

Bavarian Nordic Announces First Half 2024 Results

COPENHAGEN, Denmark, August 22, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calendar for 2025. Revenue for the first half was DKK 2,259 million, and the operating profit (EBITDA) was DKK 441 million.Revenue from travel health increased by 15% to DKK 1,119 million and revenue from public preparedness was DKK 1,024 million, which is in line with the Company's expectations...
Nasdaq GlobeNewswire
22/08/2024

Crossject to Present at the H.C. Wainwright 26th Annual Global Investment…

Press ReleaseDijon, France August 22, 2024 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma companydeveloping medicines for emergency situations harnessingits award-winning needle-free auto-injector ZENEO®,announced that it will present virtually and participate in one-on-one investor meetings at the H.C. Wainwright 26th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel in New York City fromSeptember 9th-11th,...
Nasdaq GlobeNewswire
22/08/2024

Interim Report Q2 2024: Strong execution leading to 5% organic growth and margin…

HighlightsGN executed strongly across the three divisions resulting in 5% organic revenue growth for the GroupThe Hearing division continued to gain significant market share leading to 10% organic revenue growth, resulting in 5.3 percentage point increase in the divisional profit margin supported by synergies and the successful ReSound Nexia roll-outThe Enterprise division continued its focused execution leading to -3% organic revenue growth in a stabilizing market. The divisional...
Nasdaq GlobeNewswire
22/08/2024
Altri  Comunicati